At Wave 1, a venous blood sample (25 mL) was collected from each participant who provided consent. Samples were transported to a central laboratory in temperature-controlled shipping boxes where they were centrifuged, aliquoted into cryovials and stored at −80°C. Cystatin C and creatinine were measured simultaneously from frozen plasma. Cystatin C was measured using a second-generation particle-enhanced immunoturbidimetric assay (Roche Tina-quant) on a Roche Cobas 701 analyser. The assay has a measuring range of 0.40–6.80 mg/L and is traceable to the European reference standard material (ERM-DA471/IFCC) for cystatin C. Creatinine was measured on the same analyser using an enzymatic method traceable to isotope-dilution mass spectrometry. GFR was estimated using the Chronic Kidney Disease Epidemiology Collaboration equations for cystatin C [18 (link)] or creatinine [19 (link)].